Clinical Trials List
2021-02-25 - 2024-06-05
Phase III
Recruiting9
ICD-10N25.9
Disorder resulting from impaired renal tubular function, unspecified
ICD-9588.9
Unspecified disorder resulting from impaired renal function
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chia-Te Liao Division of Nephrology
- 林裕峯 Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- Yu-Wei Chen 未分科
- Mei-Yi Wu Division of Nephrology
- I-jen Chiu Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- Li-Yee Hong Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TUNG-MIN YU Division of Nephrology
- 蔡尚峰 Division of Nephrology
- CHENG-HSU CHEN Division of Nephrology
- 吳軍毅 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 孫樵隱 Division of Nephrology
- 許恆榮 Division of Nephrology
- I-WEN WU Division of Nephrology
- Chun-Yu Chen Division of Nephrology
- 李進昌 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭本忠 未分科
- Wen-Chin Lee 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝君儀 未分科
- Yung-Chang Chen 未分科
- Ya-Chung Tian 未分科
- 湛茗任 未分科
- Chih-Shiang Chang 未分科
- HSIANG-HAO HSU 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEN-CHIH CHIANG 未分科
- VIN-CENT Wu 未分科
- - - 未分科
- SHUEI-LIONG LIN 未分科
- Jenq-Wen Huang 未分科
- 楊紹佑 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳靜怡 Division of Nephrology
- Te-Chao Fang Division of Nephrology
- Shu-Ching Yeh Division of Nephrology
- Chih-Chin Kao Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
90 participants
-
Global
2800 participants
